Medulloblastoma (MB) is the most common malignant brain tumor in children. Cancer initiating cells (CICs) have been proposed to be involved in the development of brain tumors including MB. Prominin-1 antigen (CD133) is a candidate surface molecular marker for CICs. In the present study, CD133-positive cells were isolated from human Daoy MB cells and their gene expression was compared with that of control Daoy cells. DNA microarray analysis revealed that there were 398 up-regulated genes (>2-fold increase) and 318 down-regulated genes (<50% decrease) in the CD133positive cell-enriched fractions. Up-regulated genes included neuregulin-1, cyclin D1, cyclin-dependent kinase 6, vascular endothelial growth factor, inhibin β A, promyelocytic leukemia gene, MYC, and hairy enhancer of split-1, which are components of growth signaling pathways. Molecular studies suggest that developmentally regulated signals important for stem cell maintenance are also involved in MB tumorigenesis. Moreover, these molecules can serve as novel targets for MB treatment.
Introduction
Medulloblastoma (MB) is the most common malignant brain tumor in childhood and is thought to arise from precursor cells in the cerebellar granule cell lineage (1) . MB patients are now divided into stratification groups according to age, degree of resection and disease dissemination, and are treated depending upon risk. Although the use of multidisciplinary approaches and stratification management of the disease have improved prognosis, 50% of patients, particularly in the high-risk group, experience disease recurrence, dissemination to the cerebrospinal fluid space, and/or a high incidence of sequelae (2) .
The concept regarding the existence of cancer stem cells or cancer initiating cells (CICs) is currently a focal point. The hypothesis that cancerous cells originate from rare populations of CICs that are more tumorigenic than other cancer cells has gained increasing credence (3) . CICs are thought to persist in tumors as a distinct population that can cause tumor recurrence and distant metastasis. The existence of CICs in MB has also been reported (4, 5) . Prominin-1 antigen (CD133) was identified in hematopoietic stem cells (6, 7) and neuroepithelial stem cells (8) and has generally been used as a marker for CICs (9) . Although some investigators assert that CD133 is not an adequate marker of CICs since both CD133-positive and -negative cells are able to initiate tumors (10) , it is also true that CIC-like cells that exhibit self-renewal and multipotential properties are restricted in the CD133-positive cell fractions. In the present study, CD133-positive cells were isolated from the human Daoy MB cell line using magnetic-activated cell sorting (MACS) beads and the transcript profiles of CD133-positive Daoy MB cells were investigated using DNA microarray analysis in order to obtain a better understanding of the molecular properties of CICs involved in MB tumorigenesis.
Materials and methods
Cell culture. The human Daoy medulloblastoma (MB) cell line was purchased from the American Type Culture Collection (ATCC) and cultured in Dulbecco's modified Eagle's medium (DMEM; Sigma-Aldrich, Inc., St. Louis, MO, USA) with 10% fetal bovine serum (FBS; Sigma-Aldrich, Inc.), 100 U/ml penicillin, and 100 µg/ml streptomycin at 37˚C under 5% CO 2 .
Flow cytometry. Cells were detached in phosphate-buffered saline (PBS) containing 0.25% trypsin and 0.02% EDTA for 3 min at 37˚C under 5% CO 2 , and the reaction was stopped by adding complete medium (DMEM with 10% FBS). Following centrifugation at 1000 rpm for 5 min, the cells were washed and resuspended in bovine serum albumin (BSA)/PBS buffer (PBS with 0.1% BSA and 2 mM EDTA). Half of the cells were incubated with FcR blocking reagent (Miltenyi Biotec Inc., Auburn, CA, USA) and anti-CD133-PE (Miltenyi Biotec Inc.) for 10 min at 4˚C, and the remaining cells were incubated with IgG-PE (BD Biosciences, San Jose, CA, USA) as controls. After washing, the cells were resuspended in BSA/PBS buffer and analyzed using the Beckman Coulter Epics xL system (Beckman Coulter, Inc., Chaska, MN, USA). The data were analyzed using FlowJo software (Tree Star Inc., Ashland, OR, USA).
Cell sorting. CD133-positive Daoy cells were sorted using the CD133 cell isolation kit (Miltenyi Biotec Inc.). Briefly, cells were suspended in BSA/PBS buffer, incubated with FcR blocking reagent and CD133 microbeads (Miltenyi Biotec Inc.) for 30 min at 4˚C. To determine the sorting efficiency, the cells were incubated with anti-CD133/2-PE for 10 min. Following washing and centrifugation, the cells were resuspended in BSA/PBS buffer, loaded onto a magnetic separation column (Miltenyi Biotec Inc.) and placed in a magnetic cell separator. The column was rinsed, and the magnetically labeled cells were flushed out with elution buffer and collected. These cells were used in the subsequent experiments.
DNA microarray analysis. Total RNAs were isolated from the CD133-positive Daoy cells (sorted and control) using TRIzol™ (Invitrogen, Carlsbad, CA, USA). Synthesis and labeling of cRNAs and hybridization of biotin-labeled cRNA probes to the Human Genome U133A 2.0 expression Chip arrays (Affymetrix, Santa Clara, CA, USA) were performed according to the manufacturer's protocol. The imaging screens were scanned and analyzed using the Affymetrix Microarray Suite and GeneSpring Gx (Agilent Technologies, Santa Clara, CA, USA).
Semi-quantitative reverse-transcriptase polymerase chain reaction (RT-PCR) analyses. Total RNAs were prepared and used as templates for cDNA synthesis with random hexanucleotide primers and SuperScript reverse transcriptase II (Invitrogen). Real-time PCR analyses were performed using a QuantiTect SYBR-Green PCR kit (Takara, kyoto, Japan) and a LightCycler System (Roche, Basel, Switzerland). The PCR primer sequences were determined using WWW primer tool, Primer3 (http://biotools.umassmed.edu/bioapps/primer3_www. cgi) ( Table I ). The transcript abundance of the genes of interest was normalized to that of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA as an internal standard. At least 3 independent analyses were performed for each sample and for each gene.
Results

CD133-positive Daoy MB cells were highly enriched by MACS.
Flow cytometry showed that 3-5% of Daoy cells expressed prominin-1 antigen (CD133) and CD133/2 antigens. After MACS was applied, the CD133-positive cells were highly enriched (>60%). These cells were then used in the DNA microarray gene expression analyses.
Transcript analysis in CD133-positive MB cells. Transcript analysis using DNA microarrays was performed, and the acquired data were filtered according to the gene expression level. In comparison with the control Daoy cells, the CD133positive cell-enriched fractions exhibited a >2-fold increase in the expression of 398 genes, and a <50% decrease in the expression of 318 genes. A number of molecules involved in the growth signaling pathways, which play important roles both in MB oncogenesis and stem cell proliferation, were up-regulated in the CD133-positive cell-enriched fractions. These molecules included neuregulin-1 (NRG1; which showed a 6.818-fold increase), cyclin D1 (CCND1; 5.636), cyclin-dependent kinase 6 (CDk6; 3.564), vascular endothelial growth factor (vEGF; 3.186), inhibin β A (INHBA; 3.115), Jagged 1 (JAG1; 2.702), promyelocytic leukemia gene (PML; 2.538), MYC (2.479), and hairy enhancer of split-1 (HES1; 2.078) (Table II) . On the other hand, neural differentiation markers or developmentally Table I . RT-PCR primer sequences of the genes of interest. Genebank  Sense  Antisense   NRG1  NM013959  TTGGTGCTGCTTTCTTGTTG  CGGAGCCTCACACACCTATT  CCND1  BC000076  TCCTCTCCAAAATGCCAGAG  TGAGGCGGTAGTAGGACAGG  CDk6  NM001259  AGGGTGCAGTCAAAACAACC  TCCCATCCACTTCAAAGGAG  vEGF  AF091352  TGCAGATTATGCGGATCAAA  GCGAGTCTGTGTTTTTGCAG  INHBA  M1343  AGACGCTGCACTTCGAGATT  CCCTTTAAGCCCACTTCCTC  JAG1  U73936  AGCTGGCTTACACTGGCAAT  AAGTGGGAGCTCAAAGACCA  MYC  NM002467  CTCCTGGCAAAAGGTCAGAG  TCGGTTGTTGCTGATCTGTC  HES1 NM005524
Gene symbol
U89330 AAGAAGGTCGCCATCATACG GGCGGATGTTCTTCAGAGAG GAPDH TGCACCACCAACTGCTTAG GAGGCAGGGATGATGTTC The genes of interest are indicated in boldface type.
regulated genes, expressed in the granule cell lineage, such as neurofascin (NFASC; 0.0608), apolipoprotein E (APOE; 0.296), astrotactin (ASTN; 0.392), neurofilament light polypeptide 68 kDa (NEFL; 0.418), and microtubule-associated protein 2 (MAP2; 0.49) were down-regulated (Table II) .
Semi-quantitative RT-PCR analyses were then performed in the selected genes (up-regulated genes, Fig. 1A ; downregulated genes, Fig. 1B ) and the gene expression changes were confirmed to be significant.
Discussion
In the present study, we first isolated CD133-positive cells in the human Daoy medulloblastoma (MB) cell line. The percentage of CD133-positive cells was approximately 3-5%, which was in accordance with previous studies (0.5-10%) (11, 12) . After MACS was applied, the percentage of CD133-positive cells was noted to be greater than 60%. These enriched cell fractions were subsequently subjected to transcript analysis using DNA microarrays. Transcript analysis using DNA microarrays identified various molecules that were components of the growth signaling pathways, which play important roles both in MB oncogenesis and stem cell proliferation. The genes which exhibited up-regulated expression included the activator of MAP kinase signal (RGS16), a ligand of ERBB (EGF signal component; NRG1), Wnt signal targets CCND1 and c-myc, a ligand of Notch signal (JAG1), and its target (HES1) (13) (14) (15) (Table II) . c-myc is known to play a key role in stem cell selfrenewal and was used to produce induced pluripotent stem cells (16) . The Wnt and Notch pathways are involved in the maintenance of stem cell properties and in MB oncogenesis (17) (18) (19) . The remaining up-regulated genes included INHBA, an inhibitor of differentiation factors, such as activin and TGF β, and vEGF which plays a role in the neovascularization of tumors (20, 21) . These genes may be involved in tumor recurrence or distant metastasis.
In contrast, the genes whose expression decreased to less than 50% included the neural markers (MAP2 and NEFL) (22, 23) , developmentally regulated genes in the cerebellar granule cell lineage (NFASC, UNC5B, ASTAN, SLIT3 and APOE) (24) (25) (26) (27) , and molecules involved in retinoic acidinduced apoptosis in neuroblastoma (RBP1, BMP2, RARRES2 and CASP4) (28, 29) . Down-regulation of these genes may result in the inhibition of differentiation and maintenance of undifferentiated properties of CICs or may contribute to the inhibition of cell death, thereby providing infertility to CICs.
An understanding of the molecular pathway involved in MB oncogenesis has been advanced by analyses of the Turcot-and Gorlin-inherited syndromes which are associated with the development of MB. The Wnt and sonic hedgehog (SHH) signal pathways are involved in MB oncogenesis in the Turcot and Gorlin syndromes, respectively (30) (31) (32) (33) . In addition, the Notch, epidermal growth factor receptor ERBB, and platelet-derived growth factor (PDGF) signaling pathways are involved in MB oncogenesis or prognosis (33) (34) (35) (36) (37) . These pathways play crucial roles in the proliferation and/or differentiation of the cerebellar granule cell lineage where MB originates. Furthermore, molecular studies have shown that developmentally regulated signals, such as Wnt, SHH and Notch, play important roles in self-renewal, proliferation and/or the multipotency of stem cells, and are also involved in MB oncogenesis (17) (18) (19) . These molecular studies and the results of the present study indicate that further understanding of the molecular properties and fundamental signaling pathways of CICs involved in MB oncogenesis may lead to the 
